PREVIOUS
✖
First Indigenous Dengue Vaccine
July 7 , 2025
16 hrs 0 min
29
0
- India’s first indigenous tetravalent dengue vaccine, DengiAll, has reached 50% enrolment in Phase 3 clinical trials.
- DengiAll is developed by Panacea Biotec under a license from the US National Institutes of Health (NIH).
- The vaccine targets all four dengue virus subtypes (DEN-1, DEN-2, DEN-3, DEN-4).
- Dengue is a mosquito-borne viral disease spread by the female Aedes aegypti mosquito.
Leave a Reply
Your Comment is awaiting moderation.